0.369
전일 마감가:
$0.3789
열려 있는:
$0.379
하루 거래량:
138.15K
Relative Volume:
0.69
시가총액:
$5.67M
수익:
-
순이익/손실:
$-19.09M
주가수익비율:
-0.17
EPS:
-2.17
순현금흐름:
$-16.92M
1주 성능:
-4.40%
1개월 성능:
-3.91%
6개월 성능:
-35.83%
1년 성능:
-63.10%
Organovo Holdings Inc Stock (ONVO) Company Profile
명칭
Organovo Holdings Inc
전화
858-224-1000
주소
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
ONVO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ONVO
Organovo Holdings Inc
|
0.369 | 5.67M | 0 | -19.09M | -16.92M | -2.17 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2018-12-13 | 개시 | H.C. Wainwright | Buy |
2017-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2017-01-25 | 개시 | Raymond James | Outperform |
2015-08-11 | 다운그레이드 | Cantor Fitzgerald | Buy → Hold |
2015-06-29 | 개시 | Jefferies | Buy |
2015-06-29 | 개시 | Piper Jaffray | Overweight |
모두보기
Organovo Holdings Inc 주식(ONVO)의 최신 뉴스
Organovo Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Organovo: Fiscal Q3 Earnings Snapshot - Thehour.com
Organovo: Fiscal Q3 Earnings Snapshot -February 19, 2025 at 09:18 am EST - Marketscreener.com
ORGANOVO HOLDINGS, INC. SEC 10-Q Report - TradingView
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Organovo Holdings Delays Quarterly Report Filing - TipRanks
3D Bioprinting and Bioink Market is set to Fly Massive Growth in Years to Come: Organovo, Cellink, RegenHU - openPR
Organovo (NASDAQ:ONVO) Research Coverage Started at StockNews.com - Defense World
3D Bioprinting Market Research Report USD 6.4 Billion - openPR
Organovo (ONVO) Projected to Post Earnings on Thursday - Defense World
Organ On Chip Market Growing Rapidly: Emulate Inc., Mimetas B.V., Insphero, Organovo Holdings - openPR
Next Generation Bioprinting Market Top Companies StudyEOS - openPR
3D Bioprinting Market: Future Scope, Growth Potential, - openPR
Organovo faces potential Nasdaq delisting - MSN
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
3D Bioprinting Technology Market to Witness Stunning Growth | - openPR
Organovo faces potential Nasdaq delisting By Investing.com - Investing.com UK
3D Bioprinting in Medical Market Worth $4.9 billion by 2032 | - openPR
Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Organovo names new CFO amid clinical advancements By Investing.com - Investing.com Nigeria
Organovo Appoints Norman Staskey as Chief Financial Officer - citybiz
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer - The Manila Times
Organovo names new CFO amid clinical advancements - Investing.com
Organovo Appoints M&A Veteran CFO as FXR314 Drug Shows Promising Phase 2 Results - StockTitan
Organovo (NASDAQ:ONVO) Coverage Initiated at StockNews.com - Defense World
Organovo appoints new president and CFO amid strategic plans By Investing.com - Investing.com Nigeria
Organovo appoints new president and CFO amid strategic plans - Investing.com India
Organovo Holdings Appoints Norman Staskey as New CFO - TipRanks
Analyzing Sorrento Therapeutics (OTCMKTS:SRNEQ) and Organovo (NASDAQ:ONVO) - Defense World
Top 10 4D Printing Companies | Provides Best TechMarket.us Scoop - Market.us Scoop - Market News
Healthcare 4D Printing Market Top Companies Study3D Systems - openPR
3D Print Organ Market 2024 to Witness Huge Growth by 2032 Prominent Players are Organovo Holdings, EnvisionTEC - openPR
3D Bioprinting for Tissue and Organ Regeneration Market Top - openPR
3D Bioprinting Equipment Sales Market Overview, Future Trends - openPR
3D-Printed Organs Market is experiencing new opportunities & competitive edge highlighted by Top Market Key Players (Organovo Holdings Inc., Modern Meadow, Poietis, REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc.) | Forecast to 2030 - Industry Today
Empowering Growth: Bioprinting Services Market 2024 - openPR
3D Bioprinting Market is Forecast to Achieve USD 2.0 Billion - openPR
ONVO (Organovo Holdings) Enterprise Value : $5.31 Mil (As of Dec. 01, 2024) - GuruFocus.com
Organovo expands equity incentive plan following stockholder approval By Investing.com - Investing.com Nigeria
Organovo expands equity incentive plan following stockholder approval - Investing.com
Organovo Holdings Gains Approval for Key Strategic Moves - TipRanks
Industrial 3D Printing Market Size Analysis and Top Companies - Precedence Research
ONVOOrganovo Holdings Inc. Latest Stock News & Market Updates - StockTitan
Organovo reports positive Phase 2 results for liver drug FXR314 By Investing.com - Investing.com Australia
Organovo reports positive Phase 2 results for liver drug FXR314 - Investing.com India
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - The Manila Times
Organovo Holdings Inc (ONVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):